Stay updated on Sitagliptin in GVHD Prevention Clinical Trial
Sign up to get notified when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.
Latest updates to the Sitagliptin in GVHD Prevention Clinical Trial page
- Check5 days agoChange DetectedRevision: v3.3.3 is added to the record history; HHS Vulnerability Disclosure and Revision: v3.3.2 entries are removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%
- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check34 days agoChange DetectedA new revision entry v3.3.2 was added to the record history, and the older v3.2.0 entry was removed.SummaryDifference0.1%
- Check41 days agoChange DetectedThe government funding/operating status banner is removed from the page.SummaryDifference0.7%
- Check55 days agoChange DetectedNo significant differences were detected between the old and new screenshots; the study record content and structure appear unchanged.SummaryDifference0.1%
- Check84 days agoChange DetectedUpdate includes a prominent operating-status notice and a version upgrade from v3.1.0 to v3.2.0. The core effect is informing users about possible delays and the current open status of the NIH Clinical Center.SummaryDifference12%
- Check91 days agoChange DetectedVersion bump from v3.0.2 to v3.1.0; no other content changes are shown.SummaryDifference0.3%
Stay in the know with updates to Sitagliptin in GVHD Prevention Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Sitagliptin in GVHD Prevention Clinical Trial page.